Tumorerkrankungen-Reference-Cited by-同舟云学术

Tumorerkrankungen

Published:2003 Issue: Volume: Page:197-279
ISSN:
Container-title:Medizinische Therapie in Klinik und Praxis
language:
Short-container-title:

Author:

Hiddemann Wolfgang,Neubauer Andreas,Possinger Kurt,Dieing Annette,Otto Thomas,Krege Susanne,Rübben Herbert,Hanf Volker,Kreienberg Rolf,Eberhardt Wilfried,Issels Rolf D.,Riess Hanno,Bokemeyer Carsten,Wandt Hannes,Heidemann Else,Kurzeder Christian,Zehnpfennig Dominique A.,Wendtner Clemens-Martin,Hallek Michael

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-662-12451-2_4

Reference193 articles.

1. Adamson DJA, Thompson WD, Dawson AA, Bennett B, Haites NE (1995) p53 mutation and expression in lymphoma. British Journal of Cancer 72: 150–154

2. Allan N, Richards S, Shepherd P et al. (1995) UK Medical Research Council randomized multicenter trial of interferon-alpha for chronic myeloid leukemia: Improved survival irrespective of cytogenetic response. Lancet 345: 1392

3. Bergh J, Norberg T, Sjögren S, Lindgren A, Holmberg L (1995) Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particulary in relation to adjuvant systemic therapy and radiotherapy. Nature Medicine 1: 1029–1034

4. Bosari S, Viale G, Bossi G, Maggioni M, Coggi C, Murray JJ, Lee AKC (1994) Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. Journal of National Cancer Institute 86: 681–687

5. Colombat P, Salles G, Brousse N et al. (2001) Rituximab (antiCD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation. Blood 97: 101–106